Findings of Optical Coherence Tomography of Retinal Nerve Fiber Layer in Two Common Types of Multiple Sclerosis
Multiple sclerosis (MS) is the most prevalent disease caused by the inflammatory demyelinating process that causes progressive nervous system degeneration over the time. Optical Coherence Tomography (OCT) is a non-invasive optical imaging technology, which can measure the thickness of retinal nerve fiber layer as well as the diameter of the macula. The purpose of the study is evaluation OCT findings in two common types of multiple sclerosis. For doing the cross-sectional study, 63 patients with two prevalent types of multiple sclerosis (35 patients with Relapse Remitting Multiple Sclerosis (RRMS) and 28 patients with Secondary Progressive Multiple Sclerosis (SPMS) were evaluated for 6 months. Exclusion criteria of the study were a history of optic neuritis, suffering from diabetes mellitus, hypertension, ocular disease, and the presence of other neurologic degenerative diseases. Then, the thickness of retinal nerve fiber layer (RNFL), as well as thickness and volume of the macula, were measured in the patients using OCT technology. The disability rate of patients was evaluated according to Expanded Disability Status Scale (EDSS). Finally, data was analyzed by means of SPSS software. Overall, 35 patients with RRMS (with mean age of 32.37+10.01, average disease period of 3.81+3.42 and mean EDSS of 1.84+0.45) and 28 patients with SPMS (with mean age of 39.21+9.33, average disease period of 11.32+5.87 and mean EDSS of 5.12+1.46) were assessed and compared in terms of retinal nerve fiber layer and size and thickness of macula. In all of these sections, the thicknesses were smaller in SPMS patients than patients with RRMS. But, there was a significant difference in total thickness (81.82µm versus 96.03µm with P=0.04) and thickness of temporal sector (54.5 µm versus 69.34 µm with P=0.04) of retinal nerve fiber layer and macular size at the superior sector of external ring (1.48 mm³ versus 1.58 mm³ with P=0.03), and nasal sector of external ring surrounding macula (1.53 mm³ versus 1.66 mm³ with P=0.03). No significant correlation was found among rising disability and reduced thickness of macula and optic nervous layer. Based on the study results, it can be said that OCT is a useful method for showing axonal degeneration severity and evaluation of various drugs effects on the course of MS disease, and thus we can change drugs based on OCT findings for achieving best results.
Stone J, Carson A. Functional and dissociative (Psychologenic) neurological symptoms. In: Daroff RB, Fenichel GM, Jankovic J, Mazziotta JC, eds. Bradley’s Neurologyin Clinical Practice. 6th ed. Philadelphia: Saunders, 2012:2336.
Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011;134:518-33.
Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.
Oberwahrenbrock T, Schippling S, Ringelstein M, Kaufhold F, Zimmermann H, Keser N, et al. Retinal Damage inMultiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography. Mult Scler Int 2012;2012:530305.
Costello FC, Klistorner A, Kardon R. Optical Coherence Tomography in the Diagnosis and Management of Optic Neuritis and Multiple Sclerosis. Ophthalmic Surg Lasers Imaging 2011;42:28-40.
Multiple Sclerosis In: Rowland LP, Pedley TA, editors. Merrit’s neurology. 12th ed. Philadelphia: Lippincott Williams and Wilkins, 2009:1172.
Pfueller CF, Brandt AU, Schubert F, Bock M, Walaszek B, Waiczies H, et al. Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis. PLoS One 2011;6:e18019.
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-52.
Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, et al. Axonal loss and myelin in early on loss in postacute optic neuritis. Ann Neurol 2008;64:325-31.
Fjeldstad C, BembenM, Pardo G. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography . J Clin Neurosci 2011;18:1469-72.
Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical Coherence Tomography (OCT): Imaging the Visual Pathway as a Model for Neurodegeneration. Neurotherapeutics 2011;8:117-32.
Pueyo V, Martin J, Fernandez J, Almarcegui C, Ara J, Egea C, et al. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler 2008;14:609-14.
Petzold A, Boer JF, Schippling S, Vermersch P, Kardon R, Green A, et al. Optical coherence tomography in multiple sclerosis a systematic review and meta-analysis. Lancet Neurol 2010;9:921-32.
Nikanfar M, Talebi M, Bahrabar M, Sharifipour E, Bahrebar M, Kiavar A, et al. Optic coherence tomography findings in patients with relapsing-remitting multiple sclerosis of north-west Iran. Iran J Neurol 2013;12:81-6.
McDonnell G, Hawkins S. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry1998;64:451-4.
Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007;69:2085-92.
Fatehi F,Shaygannejad V, Kiani Mehr V, Dehghani A. Optical coherence tomography versus visual evoked potential in multiple sclerosis patients. Iran J Neurol 2012;11:12-5.
Noval S, Contreras I, Munoz S, Oreja-Guevara C, Manzano B, Rebolleda G. Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An Update. Multi Scler Int 2011;2011:472790-472801.
Trip S, Schlottmann PG, Jones SJ, Li WY, Garway-Heath DF, Thompson A, et al. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage 2006;31:286-93.
Khanifar A, Parlitsis GJ, Ehrlich JR, Aaker GD, D'Amico DJ, Gauthier SA, et al. Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol 2010;4:1007-13.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
Haber A, LaRocca NG, eds. Minimal Record of Disability for multiple sclerosis. New York: National Multiple Sclerosis Society, 1985.
|Issue||Vol 54, No 6 (2016)|
|OCT Multiple sclerosis Chronic progressive|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|